Louisiana Senate Bill SR197

Louisiana 2017 Regular Session

• Introduced: 6/6/17
• Passed: 6/6/17

Caption

Urges and requests certain state universities and research entities to pursue opportunities for research on the safety and clinical efficacy of therapeutic marijuana.

Impact

This resolution emphasizes the importance of evidence-based research in evaluating therapeutic marijuana. By urging state universities and research centers to engage in clinical trials, it aims to standardize protocols and safety measures around cannabis use in medical treatment. Such actions could lead to improvements in health care for vulnerable populations, including children and the elderly, ensuring they receive proper care and consumer protection.

Summary

Senate Resolution 197 urges Louisiana State University Health Sciences Centers and other relevant institutions to pursue research opportunities regarding the safety and clinical efficacy of marijuana for therapeutic uses. The resolution recognizes the growing need for research in this area, particularly given the Act No. 96 which permits therapeutic marijuana use for patients with specific debilitating conditions. The resolution aims to enhance understanding through scientific exploration, thereby potentially benefiting patients suffering from severe medical conditions.

Sentiment

The sentiment surrounding SR197 appears largely supportive, advocating for increased research into therapeutic marijuana. However, there may be underlying concerns regarding the pacing of research and the regulatory landscape surrounding marijuana as a therapeutic option. Stakeholders, including health professionals and academic institutions, may express varying degrees of enthusiasm about the bill, reflecting broader societal discussions on cannabis use.

Contention

While the resolution itself is relatively straightforward, the implications surrounding marijuana research could provoke debate about regulatory frameworks and public health policies. Those cautious about marijuana's therapeutic use might raise questions regarding the adequacy of current studies, comparing them to established medications. There could also be discussions about access restrictions for certain populations as research progresses, particularly if therapeutic marijuana becomes more normalized in clinical settings.